MedinCell launches its initial public offering on the regulated market of Euronext in Paris
September 17, 2018
Previous PostMedinCell announces the extension of the subscription period for the shares offered as part of its initial public offering
Next PostMedinCell announces filing of its document de base with the AMF, the first step towards its planned IPO on the regulated market of Euronext in Paris